The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting its sales in the process.Regeneron accused of 'fraudulent' drug-pricing reporting for eye drug Eylea
Market Watch - 11 Apr 2024 02:35The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting its sales in the process.
Share this Article
Comments
##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes
Please to comment